Operation Commencement Date: April 16, 2013
Amendment: May 30, 2017
Display previous version
President and CEO
Katsunori Ogawa
The "Act on the Protection of Personal Information" (hereinafter "the Act"), with regard to personal information that is obtained by the Company (Name: Sony Olympus Medical Solutions Inc.), which is a business operator handling personal information, prescribes the statutory matters, such as the purpose of use, that should be published or made easily accessible to the individual.
With regard to the items set forth in 1 to 5 below, the Company states the following (the terms, etc., used are the same as those in the Domestic Sony Group Common Privacy Policy).
- 1. Information to be obained
- Stated in paragraph 1 of sections Ⅰ through Ⅳ below.
- 2. Utilization Purpose
- The purpose of use of personal information (related to Article 18 Paragraph 1 of the Act) and the purpose of use of retained personal data (related to Article 27 Paragraph 1 of the Act) at the time of acquisition (hereinafter collectively referred to as "purpose of use"). Stated in paragraph 2 of sections Ⅰ through Ⅳ below.
- 3. Joint User and Subcontractor of Personal Information (hereinafter "personal information recipient")
- Information on joint users is provided in Ⅴ-2 below. Cases where there is a subcontractor are stated in the items of sections Ⅰ through Ⅳ.
- 4. Contact Point
- "The address for reporting complaints relating to the handling of retained personal data" prescribed in Article 5 of the "Ordinance for the Enforcement of the Act on the Protection of Personal Information". Described in Ⅵ below.
- 5. Procedures for responding to requests, etc., for disclosure, etc.
- The procedures for responding to inquiries regarding notifications of the purpose of use (Related to Article 27 Paragraph 2 of the Act), disclosure (Related to Article 28 Paragraph 2 of the Act), cessation, etc., of use (Related to Article 30 Paragraph 2 of the Act), and the cessation of third party provision (Related to Article 30 Paragraph 4 of the Act) of retained personal data (hereinafter collectively referred to as "requests, etc., for disclosure, etc."). Described in Ⅶ below.
Details
- Ⅰ. Personal Information of Physicians and Other Medical Practitioners and Medical Researchers
-
- Ⅰ-1. Information to be obtained
- Information collected to the extent necessary for the purpose of use set forth in Ⅰ-2 and depending on the purpose of use, may include the following information: Name, address, telephone number, e-mail address, date of birth, gender, occupation, name of affiliated organization, address and telephone number of affiliated organization, clinical department, affiliated section, title, university graduated, year of graduation, qualifications, affiliated organization(s), image, account number and other information necessary for payment, history of transactions and inquiries, etc.
- Ⅰ-2. Purpose of use
- Following business activities related to (a) Medical device and other device (including components, units, and software) developed, manufactured, sold, or exported/imported by the Company, as well as accompanying related products, and (b) Solution services and other services provided by the Company in relation to (a) above (hereinafter collectively referred to as “Medical Products, etc.”
- Provision and collection of information related to Medical Products, etc.
- Provision and collection of medical information and academic information
- Survey and research in areas related to medical science and/or Medical Products, etc.
- Assistance for academic activities
- Subcontracting of research studies, development, or other operations related to Medical Products, etc,
- Collection and management of information related to payment
- Sales, provision, and after-sale support of Medical Products, etc.
- Application, notification, and reporting to relevant government agencies, etc.
- Ⅰ-3. Personal information recipient
- Some information may be shared with subcontractors for the purpose of use described in 2 above. Joint users are detailed in Ⅴ below.
- Ⅱ. Personal information of individuals or employees of corporations in a business relationship with the Company
-
- Ⅱ-1. Information to be obtained
- Information collected to the extent necessary for the purpose of use set forth in Ⅱ-2 and based on the purpose of use, may include the following information: Name, name of workplace, address of workplace, telephone number of workplace, e-mail address, title, account number(s) and other information necessary for payment, history of transactions and inquiries, etc.
- Ⅱ-2. Purpose of use
- Communication, negotiation, contracting, and payment to conduct transactions (including trading and subcontracting)
- Ⅱ-3. Personal information recipient
- Some information may be shared with subcontractors for the purpose of use described in 2 above. Joint users are detailed in Ⅴ below.
- Ⅲ. Personal information of persons making an inquiry with the Company
-
- Ⅲ-1. Information to be obtained
- Information collected within to the extent necessary for the purpose of use set forth in Ⅲ-2 and depending on the purpose of use, may include the following information: Name, address, telephone number, e-mail address, history of transactions and inquiries, etc.
- Ⅲ-2. Purpose of use
-
- Review and investigation of the inquiry, response to the inquiry, and record-keeping of the inquiry
- Review and investigation for identity verification of inquirers
- Communication and provision to providers of products and to medical practitioners, etc.
- Notification and reporting to relevant government agencies
- Ⅲ-3. Personal information recipient
- Some information may be shared with subcontractors for the purpose of use described in 2 above. Joint users are detailed in Ⅴ below.
- Ⅳ. Personal information of shareholders
-
- Ⅳ-1. Information to be obtained
- Information collected to the extent necessary for the purpose of use set forth in Ⅳ-2 and depending on the purpose of use, may include the following information: Name, address, number of shares, etc.
- Ⅳ-2. Purpose of use
-
- Performance of statutory obligations and accomodate exercise of shareholders’ rights
- Delivery of distributed documents and communication
- Preparation of documents based on relevant laws and regulations
- Ⅴ. Matters pertaining to joint use (Related to Article 23 Paragraph 5 Item 3 of the Act)
- Article 23 Paragraph 5 Item 3 of the Act prescribes, as an exception for third party provision, that in the event of personal data (excluding special care-required information) being used jointly with a specified party being provided to said specified party, and the fact of this along with certain matters being made easily accessible to the individual, said specified party is not regarded as a "third party" referred to in third party provision, and that personal data may be provided to said joint user without obtaining the prior consent of the individual.
The Company may, in relation to this article, jointly use the acquired personal data according to the following.
- Ⅴ-1. Personal data items that are jointly used
- Information to be obtained listed in I through Ⅲ above
- Ⅴ-2. Range of individuals or entities jointly using the personal data
-
- Ⅴ-3. Purpose of use of using individuals or entities
- Purpose of use listed in Ⅰ through Ⅲ above
- Ⅴ-4. Entity responsible for the management of personal data
- Sony Olympus Medical Solutions Inc.
- Ⅵ. Contact point for inquiries and requests for disclosure, etc. of personal information
-
- Personal Information Desk at Sony Olympus Medical Solutions Inc.
- Telephone number: 042-655-7232 (main)
Operating hours: Weekdays 10:00 - 17:00 (excluding Saturdays, Sundays, beginning and end of year, and other days specified by the Company)
Address to send the request for disclosure, etc. to: Southern Sky Tower 5F, 4-7-1 Koyasumachi, Hachioji-shi, Tokyo 192-0904
- Ⅶ. Procedures for responding to requests, etc., for disclosure, etc.
- For details on the procedure, please refer to Personal Information Desk at Sony Olympus Medical Solutions Inc.
Notes
If the Company otherwise individually indicates the purpose of use, etc. by notification to the relevant individual or by means of methods approved in the terms of use, etc., the content of the said individually indicated purpose of use, etc. will supersede the above description. Thank you for your understanding.
